264 related articles for article (PubMed ID: 32323844)
21. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K
Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117
[TBL] [Abstract][Full Text] [Related]
22. The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
Tada H; Takahashi H; Ida S; Mito I; Matsuyama T; Chikamatsu K
Anticancer Res; 2021 Feb; 41(2):885-893. PubMed ID: 33517294
[TBL] [Abstract][Full Text] [Related]
23. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
Jatana KR; Balasubramanian P; McMullen KP; Lang JC; Teknos TN; Chalmers JJ
Head Neck; 2016 Dec; 38(12):1799-1803. PubMed ID: 27265898
[TBL] [Abstract][Full Text] [Related]
24. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma.
Qiao Y; Li J; Shi C; Wang W; Qu X; Xiong M; Sun Y; Li D; Zhao X; Zhang D
Onco Targets Ther; 2017; 10():1363-1373. PubMed ID: 28424552
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
[TBL] [Abstract][Full Text] [Related]
28. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
29. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
[TBL] [Abstract][Full Text] [Related]
30. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance.
Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML
Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209
[TBL] [Abstract][Full Text] [Related]
31. Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance.
Grisanti S; Almici C; Consoli F; Buglione M; Verardi R; Bolzoni-Villaret A; Bianchetti A; Ciccarese C; Mangoni M; Ferrari L; Biti G; Marini M; Ferrari VD; Nicolai P; Magrini SM; Berruti A
PLoS One; 2014; 9(8):e103918. PubMed ID: 25105871
[TBL] [Abstract][Full Text] [Related]
32. Significance of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: initial results.
Jatana KR; Balasubramanian P; Lang JC; Yang L; Jatana CA; White E; Agrawal A; Ozer E; Schuller DE; Teknos TN; Chalmers JJ
Arch Otolaryngol Head Neck Surg; 2010 Dec; 136(12):1274-9. PubMed ID: 21173379
[TBL] [Abstract][Full Text] [Related]
33. [Peripheral blood circulating tumor cells in local advanced head and neck squamous cell carcinoma].
Lou JL; Guo L; Zheng WH; Zhao JZ; Zhao JQ; Liang Z; Wang SY; Fang MY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):824-829. PubMed ID: 29141291
[No Abstract] [Full Text] [Related]
34. Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes.
Morgan TM; Wang X; Qian X; Switchenko JM; Nie S; Patel KR; Cassidy RJ; Shin DM; Beitler JJ
Clin Transl Oncol; 2019 Mar; 21(3):342-347. PubMed ID: 30084036
[TBL] [Abstract][Full Text] [Related]
35. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy.
Chen W; Li Y; Yuan D; Peng Y; Qin J
Thorac Cancer; 2018 Aug; 9(8):956-966. PubMed ID: 29893036
[TBL] [Abstract][Full Text] [Related]
36. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
[TBL] [Abstract][Full Text] [Related]
37. Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma patients.
Zhang X; Weeramange CE; Hughes BGM; Vasani S; Liu ZY; Warkiani M; Hartel G; Ladwa R; Thiery JP; Kenny L; Breik O; Punyadeera C
Cell Mol Life Sci; 2024 May; 81(1):233. PubMed ID: 38780775
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Wang Z; Cui K; Xue Y; Tong F; Li S
Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
[TBL] [Abstract][Full Text] [Related]
39. Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.
Garrel R; Mazel M; Perriard F; Vinches M; Cayrefourcq L; Guigay J; Digue L; Aubry K; Alfonsi M; Delord JP; Lallemant B; Even C; Daurès JP; Landais P; Cupissol D; Alix-Panabières C
Clin Chem; 2019 Oct; 65(10):1267-1275. PubMed ID: 31387885
[TBL] [Abstract][Full Text] [Related]
40. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
Tinhofer I; Konschak R; Stromberger C; Raguse JD; Dreyer JH; Jöhrens K; Keilholz U; Budach V
Ann Oncol; 2014 Oct; 25(10):2042-2047. PubMed ID: 25057171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
